Fortieth Annual Symposium
Description: This program is designed to provide attendees with practical information about recent developments, current practices, controversies and laboratory management issues relative to transfusion medicine.
Who Should Attend: This program will be of interest to all healthcare providers who participate in the collection, production, transfusion and monitoring of blood products.
Upon the completion of this activity, participants should be able to:
- List steps taken to develop a test for antibody detection of antibodies to COVID-19 virus using column agglutination methodology.
- Review the history of use of convalescent plasma.
- Construct an overview of the data on use of COVID-19 convalescent plasma.
- Describe the real world evidence data on COVID-19 convalescent plasma.
- Summarize the conclusions regarding use of convalescent plasma.
- Describe FDA's guidance on bacterial contamination of platelets and strategies to be in compliance.
- List implementation steps and data for using whole blood in a massive transfusion setting.
- Develop appropriate patient and donor care strategies from examples described during case reviews.
- Describe changes in the BB/TM formal training since 1995.
- Explain values of coaching/mentorship and sponsorship.
- Review clinical aspects of red cell transfusion in a frequently transfused population.
- Discuss the sequential events leading to the discovery of HCV and the prospects for global eradication.
Level of Instruction
Intermediate to Advanced
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of ARCBS. Information is presented for educational purposes only.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Red Cross Blood Services (ARCBS) and The National Institutes of Health, Clinical Center, Department of Transfusion Medicine. ARCBS is accredited by the ACCME to provide continuing medical education for physicians.
The American Red Cross Blood Services designates this educational activity for a maximum of 5.5 credits AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. A maximum of 5.5 SUCCESS™ CEU credits will be awarded to laboratory professionals participating in this activity.
The American Red Cross offers the SUCCESS™ continuing education program to blood bankers and physicians. Attendees of the Symposium will receive certificates certifying their participation via email after the Symposium.
Disclosure Statement All faculty participating in continuing medical education programs sponsored by ARCBS are expected to disclose to the program audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).